Scotia Capital’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-11,735
Closed -$165K 859
2024
Q4
$165K Sell
11,735
-59,993
-84% -$886K ﹤0.01% 804
2024
Q3
$851K Sell
71,728
-44,270
-38% -$459K ﹤0.01% 538
2024
Q2
$1.08M Buy
115,998
+55,628
+92% +$284K 0.01% 482
2024
Q1
$214K Buy
+60,370
New +$209K ﹤0.01% 756

Other funds holding CORZ

Scotia Capital's CORZ Position: Q1 2025 in Review

Scotia Capital sold out of Core Scientific (CORZ) in Q1 2025, closing a stake of 11,735 shares — an estimated $165K sold.

Scotia Capital first reported a position in CORZ in Q1 2024 and held it in 4 quarters. The position peaked at $1.08M in Q2 2024. 336 funds tracked by Wall St. Rank hold CORZ as of Q1 2025.

  • Scotia Capital reported no remaining Core Scientific position as of Q1 2025 after selling out during the quarter.
  • Scotia Capital sold 11,735 Core Scientific shares in Q1 2025, an estimated $165K.
  • Scotia Capital first reported a position in Core Scientific in Q1 2024 and held it in 4 quarters.
  • Scotia Capital's Core Scientific position peaked at $1.08M in Q2 2024.
  • 336 funds tracked by Wall St. Rank held Core Scientific as of Q1 2025.

Based on Scotia Capital's 13F filing for Q1 2025, filed 9 May 2025.